Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Global Diagnostic Imaging Agent market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Diagnostic Imaging Agent market research.
Key manufacturers engaged in the Diagnostic Imaging Agent industry include GE HealthCare, Bracco Diagnostic, Guerbet, Mallinckrodt, Lantheus, Yantai Dongcheng, Foshan Rui Diao Pharmaceutical, Cardinal Health and Blue Earth Diagnostics, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Diagnostic Imaging Agent were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Diagnostic Imaging Agent market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Diagnostic Imaging Agent market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Segment by Type
Segment by Application
Consumption by Region
The Diagnostic Imaging Agent report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index
1 Diagnostic Imaging Agent Market Overview
1.1 Product Overview and Scope of Diagnostic Imaging Agent
1.2 Diagnostic Imaging Agent Segment by Type
1.2.1 Global Diagnostic Imaging Agent Market Value Comparison by Type (2023-2029)
1.2.2 Conjugated Imaging Agent
1.2.3 Metabolic Imaging Agent
1.2.4 Blood Flow and Blood Volume Imaging Agents
1.3 Diagnostic Imaging Agent Segment by Application
1.3.1 Global Diagnostic Imaging Agent Market Value by Application: (2023-2029)
1.3.2 Tumor
1.3.3 Heart Disease
1.3.4 Gastrointestinal Disease
1.3.5 Neurological Disease
1.4 Global Diagnostic Imaging Agent Market Size Estimates and Forecasts
1.4.1 Global Diagnostic Imaging Agent Revenue 2018-2029
1.4.2 Global Diagnostic Imaging Agent Sales 2018-2029
1.4.3 Global Diagnostic Imaging Agent Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Diagnostic Imaging Agent Market Competition by Manufacturers
2.1 Global Diagnostic Imaging Agent Sales Market Share by Manufacturers (2018-2023)
2.2 Global Diagnostic Imaging Agent Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Diagnostic Imaging Agent Average Price by Manufacturers (2018-2023)
2.4 Global Diagnostic Imaging Agent Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Diagnostic Imaging Agent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Diagnostic Imaging Agent, Product Type & Application
2.7 Diagnostic Imaging Agent Market Competitive Situation and Trends
2.7.1 Diagnostic Imaging Agent Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Diagnostic Imaging Agent Players Market Share by Revenue
2.7.3 Global Diagnostic Imaging Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Diagnostic Imaging Agent Retrospective Market Scenario by Region
3.1 Global Diagnostic Imaging Agent Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Diagnostic Imaging Agent Global Diagnostic Imaging Agent Sales by Region: 2018-2029
3.2.1 Global Diagnostic Imaging Agent Sales by Region: 2018-2023
3.2.2 Global Diagnostic Imaging Agent Sales by Region: 2024-2029
3.3 Global Diagnostic Imaging Agent Global Diagnostic Imaging Agent Revenue by Region: 2018-2029
3.3.1 Global Diagnostic Imaging Agent Revenue by Region: 2018-2023
3.3.2 Global Diagnostic Imaging Agent Revenue by Region: 2024-2029
3.4 North America Diagnostic Imaging Agent Market Facts & Figures by Country
3.4.1 North America Diagnostic Imaging Agent Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Diagnostic Imaging Agent Sales by Country (2018-2029)
3.4.3 North America Diagnostic Imaging Agent Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Diagnostic Imaging Agent Market Facts & Figures by Country
3.5.1 Europe Diagnostic Imaging Agent Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Diagnostic Imaging Agent Sales by Country (2018-2029)
3.5.3 Europe Diagnostic Imaging Agent Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Diagnostic Imaging Agent Market Facts & Figures by Country
3.6.1 Asia Pacific Diagnostic Imaging Agent Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Diagnostic Imaging Agent Sales by Country (2018-2029)
3.6.3 Asia Pacific Diagnostic Imaging Agent Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Diagnostic Imaging Agent Market Facts & Figures by Country
3.7.1 Latin America Diagnostic Imaging Agent Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Diagnostic Imaging Agent Sales by Country (2018-2029)
3.7.3 Latin America Diagnostic Imaging Agent Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Diagnostic Imaging Agent Market Facts & Figures by Country
3.8.1 Middle East and Africa Diagnostic Imaging Agent Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Diagnostic Imaging Agent Sales by Country (2018-2029)
3.8.3 Middle East and Africa Diagnostic Imaging Agent Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Diagnostic Imaging Agent Sales by Type (2018-2029)
4.1.1 Global Diagnostic Imaging Agent Sales by Type (2018-2023)
4.1.2 Global Diagnostic Imaging Agent Sales by Type (2024-2029)
4.1.3 Global Diagnostic Imaging Agent Sales Market Share by Type (2018-2029)
4.2 Global Diagnostic Imaging Agent Revenue by Type (2018-2029)
4.2.1 Global Diagnostic Imaging Agent Revenue by Type (2018-2023)
4.2.2 Global Diagnostic Imaging Agent Revenue by Type (2024-2029)
4.2.3 Global Diagnostic Imaging Agent Revenue Market Share by Type (2018-2029)
4.3 Global Diagnostic Imaging Agent Price by Type (2018-2029)
5 Segment by Application
5.1 Global Diagnostic Imaging Agent Sales by Application (2018-2029)
5.1.1 Global Diagnostic Imaging Agent Sales by Application (2018-2023)
5.1.2 Global Diagnostic Imaging Agent Sales by Application (2024-2029)
5.1.3 Global Diagnostic Imaging Agent Sales Market Share by Application (2018-2029)
5.2 Global Diagnostic Imaging Agent Revenue by Application (2018-2029)
5.2.1 Global Diagnostic Imaging Agent Revenue by Application (2018-2023)
5.2.2 Global Diagnostic Imaging Agent Revenue by Application (2024-2029)
5.2.3 Global Diagnostic Imaging Agent Revenue Market Share by Application (2018-2029)
5.3 Global Diagnostic Imaging Agent Price by Application (2018-2029)
6 Key Companies Profiled
6.1 GE HealthCare
6.1.1 GE HealthCare Corporation Information
6.1.2 GE HealthCare Description and Business Overview
6.1.3 GE HealthCare Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2018-2023)
6.1.4 GE HealthCare Diagnostic Imaging Agent Product Portfolio
6.1.5 GE HealthCare Recent Developments/Updates
6.2 Bracco Diagnostic
6.2.1 Bracco Diagnostic Corporation Information
6.2.2 Bracco Diagnostic Description and Business Overview
6.2.3 Bracco Diagnostic Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Bracco Diagnostic Diagnostic Imaging Agent Product Portfolio
6.2.5 Bracco Diagnostic Recent Developments/Updates
6.3 Guerbet
6.3.1 Guerbet Corporation Information
6.3.2 Guerbet Description and Business Overview
6.3.3 Guerbet Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Guerbet Diagnostic Imaging Agent Product Portfolio
6.3.5 Guerbet Recent Developments/Updates
6.4 Mallinckrodt
6.4.1 Mallinckrodt Corporation Information
6.4.2 Mallinckrodt Description and Business Overview
6.4.3 Mallinckrodt Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Mallinckrodt Diagnostic Imaging Agent Product Portfolio
6.4.5 Mallinckrodt Recent Developments/Updates
6.5 Lantheus
6.5.1 Lantheus Corporation Information
6.5.2 Lantheus Description and Business Overview
6.5.3 Lantheus Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Lantheus Diagnostic Imaging Agent Product Portfolio
6.5.5 Lantheus Recent Developments/Updates
6.6 Yantai Dongcheng
6.6.1 Yantai Dongcheng Corporation Information
6.6.2 Yantai Dongcheng Description and Business Overview
6.6.3 Yantai Dongcheng Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Yantai Dongcheng Diagnostic Imaging Agent Product Portfolio
6.6.5 Yantai Dongcheng Recent Developments/Updates
6.7 Foshan Rui Diao Pharmaceutical
6.6.1 Foshan Rui Diao Pharmaceutical Corporation Information
6.6.2 Foshan Rui Diao Pharmaceutical Description and Business Overview
6.6.3 Foshan Rui Diao Pharmaceutical Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Foshan Rui Diao Pharmaceutical Diagnostic Imaging Agent Product Portfolio
6.7.5 Foshan Rui Diao Pharmaceutical Recent Developments/Updates
6.8 Cardinal Health
6.8.1 Cardinal Health Corporation Information
6.8.2 Cardinal Health Description and Business Overview
6.8.3 Cardinal Health Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Cardinal Health Diagnostic Imaging Agent Product Portfolio
6.8.5 Cardinal Health Recent Developments/Updates
6.9 Blue Earth Diagnostics
6.9.1 Blue Earth Diagnostics Corporation Information
6.9.2 Blue Earth Diagnostics Description and Business Overview
6.9.3 Blue Earth Diagnostics Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Blue Earth Diagnostics Diagnostic Imaging Agent Product Portfolio
6.9.5 Blue Earth Diagnostics Recent Developments/Updates
6.10 Bayer AG
6.10.1 Bayer AG Corporation Information
6.10.2 Bayer AG Description and Business Overview
6.10.3 Bayer AG Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Bayer AG Diagnostic Imaging Agent Product Portfolio
6.10.5 Bayer AG Recent Developments/Updates
6.11 Abx Advanced Biochemical
6.11.1 Abx Advanced Biochemical Corporation Information
6.11.2 Abx Advanced Biochemical Diagnostic Imaging Agent Description and Business Overview
6.11.3 Abx Advanced Biochemical Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Abx Advanced Biochemical Diagnostic Imaging Agent Product Portfolio
6.11.5 Abx Advanced Biochemical Recent Developments/Updates
6.12 Eli Lilly and Company
6.12.1 Eli Lilly and Company Corporation Information
6.12.2 Eli Lilly and Company Diagnostic Imaging Agent Description and Business Overview
6.12.3 Eli Lilly and Company Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Eli Lilly and Company Diagnostic Imaging Agent Product Portfolio
6.12.5 Eli Lilly and Company Recent Developments/Updates
6.13 Jubilant Pharma Limited
6.13.1 Jubilant Pharma Limited Corporation Information
6.13.2 Jubilant Pharma Limited Diagnostic Imaging Agent Description and Business Overview
6.13.3 Jubilant Pharma Limited Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Jubilant Pharma Limited Diagnostic Imaging Agent Product Portfolio
6.13.5 Jubilant Pharma Limited Recent Developments/Updates
6.14 Navidea
6.14.1 Navidea Corporation Information
6.14.2 Navidea Diagnostic Imaging Agent Description and Business Overview
6.14.3 Navidea Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Navidea Diagnostic Imaging Agent Product Portfolio
6.14.5 Navidea Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Diagnostic Imaging Agent Industry Chain Analysis
7.2 Diagnostic Imaging Agent Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Diagnostic Imaging Agent Production Mode & Process
7.4 Diagnostic Imaging Agent Sales and Marketing
7.4.1 Diagnostic Imaging Agent Sales Channels
7.4.2 Diagnostic Imaging Agent Distributors
7.5 Diagnostic Imaging Agent Customers
8 Diagnostic Imaging Agent Market Dynamics
8.1 Diagnostic Imaging Agent Industry Trends
8.2 Diagnostic Imaging Agent Market Drivers
8.3 Diagnostic Imaging Agent Market Challenges
8.4 Diagnostic Imaging Agent Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research